Sudarshan Pharma IPO

Sudarshan Pharma IPO description – The company was established in 2008 as Sudarshan Specialty Chemsolve Private Limited and its name was changed to the current one in 2016. It markets pharmaceutical formulation & products in the Domestic and International markets through its own distribution network and sales force under its own brand. The company has a contract manufacturing agreement with four pharmaceutical companies. The company also supplies generic pharmaceutical formulation as – Make to order – for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.

Sudarshan Pharma supplies Active Pharmaceutical Ingredients (APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets with a presence in 5 States. To develop its export business, the company is in the process of applying for 16 formulation registrations in countries like Ghana, Georgia, Cambodia, Myanmar, Nigeria, Kenya, Malaysia & MINA region.

The management is planning for business expansion by having its own state of the art manufacturing facility at Wada, near Mumbai, Maharashtra.

Sudarshan Pharma promoters – Mr Hemal V. Mehta & Mr Sachin V. Mehta

Sudarshan Pharma – Upcoming IPO details
Subscription Dates	12 – 24 June 2019 (IPO canceled due to poor response)
IPO Price band	INR75 per share
Fresh issue	3,440,000 shares (INR25.80 crore)
Offer for sale	Nil
Total IPO size	3,440,000 shares (INR25.80 crore)
Minimum bid (lot size)	1,600 shares
Face Value	INR10 per share
Retail Allocation	50%
Listing On	NSE Emerge SME platform

Use of funds

• To set up a dedicated manufacturing facility for Pharmaceutical Business – INR12.50 crore
• Distribution and Warehousing Centre‘s & Purchase of Corporate Office – INR4.50 crore
• Additional Working Capital – INR5.25 crore
• General Corporate Expenses – INR2.80 crore
• Issue Expenses – INR0.75 crore

Sudarshan Pharma’s consolidated financial performance (in INR crore)
			FY2016	FY2017	FY2018	6M FY2019
Total revenue			37.9	55.5	89.8	60.7
Total expenses			37.8	55.3	88.8	58.7
Profit after tax			0.09	0.16	0.74	1.46

Sudarshan Pharma Industries Contact Details

Sudarshan Pharma Industries Limited 
301, 3rd Floor, Aura Biplex
Above Kalyan Jewellers, S V Road
Borivali (West), Mumbai – 400 092 Phone: +91 22 242221111
Email: [email protected]
Website: www.sudarshanpharma.com

Sudarshan Pharma IPO Subscription Details

Day	Subscription (no. of times)
Day 1	0.07
Day 2	0.14
Day 3	0.21
Day 4	0.43
Day 5	0.44
Day 6	0.44
Day 7	0.44
Day 8	0.45
Day 9

Sudarshan Pharma Valuation (For FY2018)

Earnings Per Share (EPS): INR2.90

Price/Earnings (P/E) ratio: 25.86

Return on Net Worth (RONW): 8.66%

Net Asset Value (NAV): INR18.10 per share

Registrar of Sudarshan Pharma IPO

Karvy Fintech Private Limited
Karvy Selenium Tower B, Plot 31-32,
Gachibowli, Nanakramguda,
Hyderabad – 500 032, Telangana Phone: +91 40 6716 2222 
Fax: +91 40 2343 1551 
Email: [email protected]
Website: www.karvyfintech.com

Sudarshan Pharma IPO Allotment Status

Sudarshan Pharma IPO allotment status will be available on Karvy website. Click on this link to get allotment status.

Listing performance of Sudarshan Pharma

IPO Opening Date: 12 June 2019 (IPO canceled due to poor demand)

IPO Closing Date: 24 June 2019 (IPO canceled due to poor demand)

Listing Date: To be updated

Listing Price on NSE SME: To be updated

Closing Price on NSE SME: To be updated